Sphere Bio is evolving. From microfluidics pioneer to full-scale life science tools provider. In Drug Discovery News, CEO Dale Levitzke shares how platforms like Cyto-Mine® Chroma are transforming single-cell discovery. 👉 #Biotech #SphereBio

Introducing Cyto-Mine® Chroma. 🔬 Ultra-high-throughput.🎯 Multiplex detection.⚙️ Automated precision. Screen millions of live cells in a day. Discover faster. 👉 #Biotech #SingleCellTech #CytoMineChroma

In February, we rebranded from Sphere Fluidics to Sphere Bio, marking our evolution into a fully integrated life sciences tools company. Our name now reflects our innovation, growth & expanded solutions. 🔗 #SphereBio #LifeSciences

Happy 4th of July!. Here’s to the innovators, researchers, and teams pushing science forward every day. Wishing you a joyful Independence Day from all of us at Sphere Bio🎇. #FourthOfJuly #IndependenceDay #Biotech #Innovation #SphereBio

Looking for the one-in-a-million cell?. Meet Cyto-Mine® Chroma - high-throughput, multiplexed, and built for discovery. 🔗 Learn more: #SphereBio #SingleCell #CellTherapy #Biotech #AntibodyDiscovery #Chroma

Cyto-Mine® is redefining single-cell workflows with FRET-based microfluidic screening - analyzing, imaging, and dispensing viable cells. Learn more in this new Biocompare article featuring our Director of Science Maryam Ahmadi: #CytoMine #Biotech

That’s a wrap on #AIS2025!. Thanks to everyone who connected with us in Tours. Great conversations, brilliant minds, and exciting ideas around accelerating antibody discovery with single-cell tech. Until next time!. #Biotech #SphereBio #AntibodyDiscovery #AIS2025

New article: “Unlocking Accurate and Reproducible Cell Sorting with Cyto-Mine® Chroma” by Benjamin Duckless. 🔍 Read more: #AntibodyDiscovery #CellLineDevelopment

From deep-tech roots to commercial scale-up - Sphere Bio is now a full-spectrum life science tools company. CEO Dale Levitzke shares the journey in Drug Discovery News. 🔗 #Biotech #SphereBio #LifeSciences #Innovation #ScaleUp

🌱 It’s #WorldMicrobiomeDay! Biotech opens doors to understanding microbiomes and health. Let’s uncover what’s hidden and transformative. #WorkSmallThinkBig

Streamline your cell line development. The Cyto-Cellect® Human IgG Kappa and Viability Assay Kit detects antibody secretion and cell viability, enabling faster, more confident selection of high-producing, viable clones. #CellLineDevelopment #SphereBio

See how Cyto-Mine® Chroma is changing the game in single-cell technology. Maryam Ahmadi explains in Biocompare 👉 #SingleCell #Biotech #AntibodyDiscovery #CytoMine

Just one day to go!. We're headed to AIS 2025 in Tours, France for two days of innovation & collaboration! . Catch us at Booth 11 and see how our single-cell screening technologies are accelerating therapeutic breakthroughs. Let’s connect 👋. #AIS2025 #SphereBio

We rebranded to Sphere Bio this year, reflecting our growth and broader focus on life sciences innovation. Excited for the next chapter in advancing single-cell research. #SphereBio #Rebrand #LifeSciences

Thrilled to see Maryam Ahmadi featured in Biocompare! 🔬 She dives into how Cyto-Mine® Chroma is advancing high-throughput, single-cell analysis for next-gen biologics. 📖 Read here: #Biotech #CellTherapy #SingleCellSorting #CytoMine

New article:.“Coupling Multiplexing + Functional Viability Assays with Cyto-Mine® Chroma”. 🔹 3-color viability + FRET-based detection.🔹 Pico-droplet + serial gating = high-precision screening. #AntibodyDiscovery #SphereBio

Better selection = higher success rates. The Cyto-Cellect® IgGк & Viability Assay Kit eliminates wasted effort and increases efficiency. Upgrade your screening workflow today! #Biopharma #SingleCellScreening

Analyze 40 MILLION cells a day with Cyto-Mine® Chroma - the automated single-cell platform that accelerates discovery and drives precision. Millions of cells. One streamlined workflow. Zero compromises. #SingleCellAnalysis #CytoMineChroma

We’ve partnered with Redbert Biotechnology as our exclusive distributor in China and appointed Jonathan Fu as Country Manager. This marks a major step in expanding access to our single-cell analysis tools across APAC. #Microfluidics #CellTherapy.

We rebranded to Sphere Bio back in February. Same science. Broader horizons. Still powering the future of life sciences, one cell at a time. #SphereBio #RebrandReminder